Table 1.
Comparison of EC50values (Mean ± 1 SD) for antiviral drugs against BV and HVP2
| EC50 value (μg/mL) for |
||||||||||||
| ACV | AraA | BUdR | BVdU | CDV | EDU | GCV | HBPG | IUdR | PCV | PFA | TFT | |
| BV (E90-136) | 11.0 ± 7.2 | 3.9 ± 0.1 | >200 | >200 | 13.6 ± 2.8 | 5.7 ± 3.4 | 3.5 ± 2.5 | >200 | 2.3 ± 2.2 | 3.1 ± 2.2 | >200 | 1.3 ± 0.3 |
| HVP2 (OU1-76) | 39.9 ± 13.4 | 14.3 ± 3.7 | >200 | >200 | 8.4 ± 3.4 | 12.8 ± 5.0 | 10.9 ± 2.4 | >200 | 41.9 ± 12.4 | 16.7 ± 5.7 | >200 | 0.7 ± 0.2 |
| HVP2 (X313) | 25.8 ± 3.4 | 5.0 ± 0.6 | >200 | >200 | 14.0 ± 7.4 | 2.7 ± 2.0 | 25.0 ± 13.4 | >200 | 9.3 ± 2.8 | 16.2 ± 1.5 | >200 | 1.2 ± 0.7 |